Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Roche Holding AG

0QOK
Current price
244.4 GBP +0.3 GBP (+0.12%)
Last closed 268 CHF
Sector Healthcare
Industry Drug Manufacturers - General
Exchange London Exchange
Capitalization 196 982 371 687 CHF
Yield for 12 month -4.94 %
1Y
3Y
5Y
10Y
15Y
0QOK
21.11.2021 - 28.11.2021

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland. Address: Grenzacherstrasse 124, Basel, Switzerland, 4058

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

226.03 CHF

P/E ratio

18.8268

Dividend Yield

3.56 %

Current Year

+58 777 926 271 CHF

Last Year

+63 347 740 860 CHF

Current Quarter

+28 967 519 117 CHF

Last Quarter

+29 810 407 153 CHF

Current Year

+42 943 243 429 CHF

Last Year

+44 490 873 955 CHF

Current Quarter

+20 678 786 412 CHF

Last Quarter

+22 264 457 017 CHF

Key Figures 0QOK

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 20 940 061 298 CHF
Operating Margin TTM 23.9 %
PE Ratio 18.8268
Return On Assets TTM 12.44 %
PEG Ratio 1.6388
Return On Equity TTM 37.86 %
Wall Street Target Price 226.03 CHF
Revenue TTM 60 504 747 571 CHF
Book Value 36.81 CHF
Revenue Per Share TTM
Dividend Share 9.61 CHF
Quarterly Revenue Growth YOY -6.5 %
Dividend Yield 3.56 %
Gross Profit TTM 47 878 442 974 CHF
Earnings per share 14.34 CHF
Diluted Eps TTM 14.34 CHF
Most Recent Quarter IV 2023
Quarterly Earnings Growth YOY 12.9 %
Profit Margin 19.02 %

Dividend Analytics 0QOK

Aristocrat - 25 or more consecutive years of dividend increases

Dividend growth over 5 years

14 %

Continuous growth

27 years

Payout Ratio 5 years average

57 %

Dividend History 0QOK

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 9.6
Ex Dividend Date 14.03.2024
Forward Annual Dividend Yield 3.56 %
Last Split Factor 100:1
Payout Ratio 56.07 %
Last Split Date 04.05.2011
Dividend Date 18.03.2024

Stock Valuation 0QOK

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 18.8268
Forward PE 13.7741
Enterprise Value Revenue 3.3329
Price Sales TTM 2.9975
Enterprise Value EBITDA 10.8654
Price Book MRQ 6.5759

Financials 0QOK

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 0QOK

For 52 weeks

227.15 CHF 287.84 CHF
50 Day MA 259.25 CHF
Shares Short Prior Month
200 Day MA 255.45 CHF
Short Ratio
Shares Short
Short Percent

Dynamics of changes in the value of assets

M

MOH

721.00 EUR LVMH Moët Hennessy - Louis Vuitton Société Européenne 0 (0%)
Detailed analytics
0

0KDH

70.65 USD Ormat Technologies Inc. +0.33 (+0.47%)
Detailed analytics
0

0HAU

716.40 EUR LVMH Moet Hennessy Louis Vuitton SE +1.24 (+0.16%)
Detailed analytics
C

CTO0

27.00 EUR COSTCO WHOLESALE CDR 0 (0%)
Detailed analytics
0

0NOF

164.50 USD Procter & Gamble Company +0.5 (+0.3%)
Detailed analytics